New cardiac warnings for Kaletra.
D019380:Anti-HIV Agents / Q000009:adverse effects*; D054537:Atrioventricular Block / Q000139:chemically induced; D004562:Electrocardiography / Q000187:drug effects*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006327:Heart Block / Q000139:chemically induced*; D006801:Humans; D061466:Lopinavir; D011356:Product Labeling / Q000331:legislation & jurisprudence*; D011744:Pyrimidinones / Q000009:adverse effects*; D013607:Tablets / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D013607:Tablets; D061466:Lopinavir